Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

David E Thurston

Professor of Drug Discovery, King’s College London, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences & Medicine, Franklin-Wilkins Building (FWB), 150 Stamford Street, London SE1 9NH, United Kingdom (ORCID: 0000-0001-8032-7203).

Recent stories

  • Antibodies attacking cancer cell

    Immuno-oncology agents for cancer therapySubscription

    7 MAY 2020

    Abstract: Until recently, cancer therapy comprised of four main types of treatment: surgery, radiotherapy, chemotherapy and targeted therapy. Over the past decade, immuno-oncology (IO) has emerged as a novel and important approach to cancer treatment through the stimulation of the body’s own immune system to kill cancer cells. This newly recognised method of treating cancer is rapidly developing, with many accelerated approvals by the US Food and Drug Administration and European Medicines Age

  • Blood samples

    The precision medicine approach to cancer therapy: part 2 — haematological malignanciesSubscription

    28 FEB 2020

    An overview of the anticancer agents that have been approved for use in the UK as part of a precision medicine approach for haematological malignancies, along with information relating to the relevant biomarkers and biomarker assays currently available. 

  • Polymerase chain reaction machine

    The precision medicine approach to cancer therapy: part 1 — solid tumoursSubscription

    8 NOV 2019

    An overview of the anticancer agents that have been approved for use in the UK as part of a precision medicine approach for solid tumours, along with information relating to the relevant biomarkers and biomarker assays currently available.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.